Literature DB >> 1856958

Chinese medicinal herbs reverse macrophage suppression induced by urological tumors.

J R Rittenhouse1, P D Lui, B H Lau.   

Abstract

Tumors are known to produce factors suppressing macrophage function. In this study we demonstrated in vitro suppression of macrophage chemiluminescent oxidative burst associated with viable cells and cell-free extracts of two urological neoplasms--murine renal cell carcinoma (Renca) and murine bladder tumor (MBT). Suppression was reversed by extracts of two Chinese medicinal herbs, Astragalus membranaceus (AM) and Ligustrum lucidum (LL). Murine macrophage cell line J774 was incubated with either the viable tumor cells or the cell-free tumor extract for 18 hours at 37C and 5% CO2. Chemiluminescent oxidative burst as an indicator of macrophage function was triggered by adding zymosan A suspension containing luminol and assayed in an automated luminometer. Photon emission over time was counted and the results were expressed as integrated photon emission. Significant dose-related depression of oxidative burst occurred with either the viable tumor cells or the cell-free tumor extracts. Depression was partially or completely reversed by the presence of 50-100 micrograms./ml. of either the AM or the LL extract. AM and LL have previously been shown to modulate immune response. Data from this study suggest that they may also exert their antitumor activity via abolition of tumor-associated macrophage suppression.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1856958     DOI: 10.1016/s0022-5347(17)37830-8

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  10 in total

1.  Tounongsan extract induces apoptosis in cultured Raji cells.

Authors:  Liang-Hua Fang; Rui-Ping Wang; Shou-You Hu; Li Zhang; Shen-Lin Liu
Journal:  Chin J Integr Med       Date:  2012-07-07       Impact factor: 1.978

2.  Effects of astragali radix on the growth of different cancer cell lines.

Authors:  Jiang Lin; Hui-Fang Dong; J J Oppenheim; O M Howard
Journal:  World J Gastroenterol       Date:  2003-04       Impact factor: 5.742

3.  Astragalus polysaccharides can regulate cytokine and P-glycoprotein expression in H22 tumor-bearing mice.

Authors:  Qing-E Tian; Huan-De Li; Miao Yan; Hua-Lin Cai; Qin-You Tan; Wen-Yuan Zhang
Journal:  World J Gastroenterol       Date:  2012-12-21       Impact factor: 5.742

Review 4.  A systematic review of anticancer effects of radix astragali.

Authors:  Yeehong Jung; Uimin Jerng; Sookyung Lee
Journal:  Chin J Integr Med       Date:  2015-12-07       Impact factor: 1.978

5.  Astragalus extract inhibits destruction of gastric cancer cells to mesothelial cells by anti-apoptosis.

Authors:  Di Na; Fu-Nan Liu; Zhi-Feng Miao; Zong-Min Du; Hui-Mian Xu
Journal:  World J Gastroenterol       Date:  2009-02-07       Impact factor: 5.742

6.  Effects of Astragalus polysaccharides on P-glycoprotein efflux pump function and protein expression in H22 hepatoma cells in vitro.

Authors:  Qing E Tian; Huan De Li; Miao Yan; Hua-Lin Cai; Qin-You Tan; Wen-Yuan Zhang
Journal:  BMC Complement Altern Med       Date:  2012-07-11       Impact factor: 3.659

7.  Astragalus saponins affect proliferation, invasion and apoptosis of gastric cancer BGC-823 cells.

Authors:  Tao Wang; Xiaoyan Xuan; Min Li; Ping Gao; Yuling Zheng; Wenqiao Zang; Guoqiang Zhao
Journal:  Diagn Pathol       Date:  2013-10-24       Impact factor: 2.644

8.  Developing Phytocompounds from Medicinal Plants as Immunomodulators.

Authors:  Chih-Chun Wen; Hui-Ming Chen; Ning-Sun Yang
Journal:  Adv Bot Res       Date:  2012-06-19       Impact factor: 2.175

9.  Dietary supplementation with two Lamiaceae herbs-(oregano and sage) modulates innate immunity parameters in Lumbricus terrestris.

Authors:  D A Vattem; Ce Lester; Rc Deleon; By Jamison; V Maitin
Journal:  Pharmacognosy Res       Date:  2013-01

10.  Preliminary Efficacy and Safety of Reishi & Privet Formula on Quality of Life Among Non-Small Cell Lung Cancer Patients Undergoing Chemotherapy: A Randomized Placebo-Controlled Trial.

Authors:  Jie Liu; Jun J Mao; Susan Qing Li; Hongsheng Lin
Journal:  Integr Cancer Ther       Date:  2020 Jan-Dec       Impact factor: 3.279

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.